Invitae News

This is selected news for Invitae, which is filed under Sectors / Healthtech. There are 84 news items for this page.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source
9/25/2022 Invitae real citizen data used in Praxis Precision Medicines PRAX-222 IND file
Health Invitae real citizen data used in Praxis Precision Medicines PRAX-222 IND file 2 (adsbygoogle = window.adsbygoogle []).push({}); (adsbygoogle = window.adsbygoogle []).push({}); (adsbygoogle = window.adsbygoogle []).push({}); ‚Ai First use of Ciitizen as a source of real-world data in regulatory filing ‚Ai (adsbygoogle = window.adsbygoogle []).push({}); San Francisco And the BostonAnd the September ...
google.com
9/25/2022 Invitae (NYSE:NVTA) Upgraded by StockNews.com to Sell - Ticker Report
Invitae ( NYSE:NVTA ‚Ai Get Rating ) was upgraded by equities researchers at StockNews.com to a ‚Ausell‚Au rating in a note issued to investors on Friday. Several other analysts have also recently commented on NVTA. Raymond James cut Invitae from an ‚Auoutperform‚Au rating to a ‚Aumarket perform‚Au rating ...
Ticker Report
9/25/2022 StockNews.com Upgrades Invitae (NYSE:NVTA) to “Sell”
Invitae (NYSE:NVTA ‚Ai Get Rating) was upgraded by equities research analysts at StockNews.com to a ‚Ausell‚Au rating in a research report issued to clients and investors on Friday. NVTA has been the topic of a number of other research reports. Cowen downgraded Invitae from an ‚Auoutperform‚Au rating ...
baseballnewssource.com
9/25/2022 StockNews.com Upgrades Invitae (NYSE:NVTA) to “Sell”
Invitae (NYSE:NVTA ‚Ai Get Rating) was upgraded by equities research analysts at StockNews.com to a ‚Ausell‚Au rating in a research report issued to clients and investors on Friday. NVTA has been the topic of a number of other research reports. Cowen downgraded Invitae from an ‚Auoutperform‚Au rating ...
zolmax.com
9/24/2022 Clinical Practice Guidelines Recommend Genetic Testing for Those with Breast Cancer
Invitae, a leading medical genetics company, released a new study in JAMA Network Open , underscoring the clinical utility of the American Society of Breast Surgeons (ASBrS) guidelines+guidelines) recommending universal genetic testing for patients with breast cancer , and showing universal testing improves patient outcomes. Building on a previous study reported ...
clpmag.com
9/24/2022 Carnegie Capital Asset Management LLC Raises Position in Invitae Co. (NYSE:NVTA) - Watch List News watchlistnews.com
9/24/2022 Carnegie Capital Asset Management LLC Increases Position in Invitae Co. (NYSE:NVTA) etfdailynews.com
9/24/2022 Carnegie Capital Asset Management LLC Raises Position in Invitae Co. (NYSE:NVTA) defenseworld.net
9/24/2022 Invitae (NYSE:NVTA) Upgraded to Sell at StockNews.com - Financial News Live finnewslive.com
9/24/2022 Invitae (NYSE:NVTA) Upgraded to Sell at StockNews.com com-unik.info
9/24/2022 Invitae (NYSE:NVTA) Upgraded by StockNews.com to Sell - Watch List News watchlistnews.com
9/24/2022 Invitae (NYSE:NVTA) Upgraded by StockNews.com to Sell defenseworld.net
9/24/2022 Invitae (NYSE:NVTA) Shares Gap Up to $2.77 - Ticker Report Ticker Report
9/23/2022 Why Invitae Corporation Sank as Much as 25.5% This Week - NewsBreak newsbreak.com
9/23/2022 Invitae Busted Business Model Offers A Tactical Opportunity Seeking Alpha
9/23/2022 Invitae (NYSE:NVTA) Trading 9.5% Higher - Watch List News watchlistnews.com
9/22/2022 Clinical Practice Guidelines Recommend Genetic Testing of All Patients with Breast Cancer PR Newswire
9/22/2022 Mirae Asset Global Investments Co. Ltd. Trims Stake in Invitae Co. (NYSE:NVTA) defenseworld.net
9/22/2022 Mirae Asset Global Investments Co. Ltd. Trims Stake in Invitae Co. (NYSE:NVTA) zolmax.com
9/22/2022 Invitae Co. (NYSE:NVTA) Shares Sold by Mirae Asset Global Investments Co. Ltd. etfdailynews.com
9/22/2022 Invitae (NYSE:NVTA) Shares Gap Up to $2.77 - Stock Observer thestockobserver.com
9/22/2022 Why Invitae Corporation Sank as Much as 25.5% This Week | Nasdaq Nasdaq
9/21/2022 Why Invitae Stock Is Jumping Today | Nasdaq Nasdaq
9/21/2022 Invitae Corporation [NVTA] Stock trading around $3.13 per share: What's Next? dbtnews.com
9/21/2022 Walleye Capital LLC Has $710,000 Stake in Invitae Co. (NYSE:NVTA) baseballnewssource.com